Literature DB >> 16760682

Clinical hypertension research tools: the randomized controlled clinical trial.

Daniel T Lackland1, Robert F Woolson.   

Abstract

The randomized clinical trial is used in hypertension research as a primary mode for evaluating new, promising therapies. Herein, the authors provide an overview of design features of clinical trials, particularly those useful for designing a hypertension therapeutic clinical trial.

Entities:  

Mesh：

Year:  2006        PMID： 16760682      PMCID： PMC8109459          DOI： 10.1111/j.1524-6175.2006.04721.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


  1 in total

1.  Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).

Authors:  H P Adams; R F Woolson; W R Clarke; P H Davis; B H Bendixen; B B Love; P A Wasek; K J Grimsman
Journal:  Control Clin Trials       Date:  1997-08
  1 in total
  3 in total

1.  Impact of COVID-19 on Clinical Research and Inclusion of Diverse Populations.

Authors:  Daniel T Lackland; Catrina Sims-Robinson; Joy N Jones Buie; Jenifer H Voeks
Journal:  Ethn Dis       Date:  2020-07-09       Impact factor: 1.847

Review 2.  Dietary salt restriction and blood pressure in clinical trials.

Authors:  Daniel T Lackland; Brent M Egan
Journal:  Curr Hypertens Rep       Date:  2007-08       Impact factor: 5.369

3.  Sodium intake and mortality: the debate continues.

Authors:  Daniel T Lackland; Brent M Egan
Journal:  J Gen Intern Med       Date:  2008-09       Impact factor: 5.128
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.